Tirzepatide TR30 30mg*10vials

Product Description

Tirzepatide 30mg × 10 vials is a high-concentration, research-grade dual-receptor peptide with high purity and stable molecular activity, designed specifically for high-standard professional laboratory research. As a potent dual agonist of GLP-1 and GIP receptors, Tirzepatide primarily regulates energy metabolism, appetite mechanisms, and body lipid balance, making it a core material for exploring metabolic regulation mechanisms, menstrual cycle regulation, and related biomedical experimental research.

This product utilizes an industry-leading 30mg high-concentration formulation, surpassing traditional 10mg, 15mg, and 20mg Tirzepatide formulations. The higher active peptide content effectively avoids experimental errors caused by excessive dilution of low-concentration reagents, simplifies experimental preparation procedures, and is perfectly suited for high-dose experimental protocols, large-scale parallel experiments, and long-term continuous research projects. It enables researchers to obtain clearer, more accurate, and reproducible experimental data, thereby significantly improving the efficiency and reliability of academic and commercial laboratory research.

This Tirzepatide product utilizes advanced vacuum freeze-drying powder technology to effectively lock in the molecular activity of the peptides, preventing component degradation and impurity formation. It boasts ultra-high purity, stable chemical properties, and excellent solubility. Each batch undergoes rigorous testing by an independent third-party laboratory and comes with complete Certificate of Account (COA) certification, fully complying with international laboratory research standards. The packaging contains 10 individually sealed sterile vials for convenient categorized storage, batch use, and sample management, fully meeting the long-term, large-scale needs of professional research institutions, biomedical laboratories, and research teams.

Key Advantages (Research Use)

- Dual activation of GLP-1 and GIP receptors, providing strong support for in-depth research on metabolic regulation, energy expenditure, and physiological appetite mechanisms.

- Ultra-high concentration of 30mg, compatible with high-dose experimental protocols, reducing reagent dilution errors and optimizing experimental procedures.

- Suitable for in-depth research on energy metabolism efficiency, lipid metabolism homeostasis, physiological regulation, and related biomedical mechanisms.

- Highly stable lyophilized powder, with good solubility, easy reconstitution, convenient transportation, and long-term sealed low-temperature storage.

- Rigorous batch testing with complete Certificate of Authorization (COA) ensures stable product quality and reliable experimental data, suitable for academic research, institutional experiments, and commercial laboratory projects.

High-concentration tezoparatide 30mg 10 vials lyophilized research peptide. Dual GLP-1 and GIP receptor agonists, suitable for advanced metabolic and physiological regulation laboratory research. High purity, with complete COA certificate.